Pent-Up Supply, Selective Demand, and Optimization-Led Innovation The biopharma IPO window has officially reopened. In the first half of 2026, biopharma companies completed 13 IPOs and raised about $5 billion,…
We provide custom solutions to all types of pharmaceutical development organizations.